A phase II study on the efficacy of regorafenib in treating patients with c-KIT-mutated metastatic malignant melanoma that progressed after previous treatment (KCSG-UN-14-13)European Journal of Cancer, 2023, v.193, 113312
A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland CancerCancer research and treatment, 2022, v.54 no.3, 719-727
Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trialGenome Medicine, 2022, v.14 no.1
Synergistic Effects of Combination Therapy with AKT and mTOR Inhibitors on Bladder Cancer CellsINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, v.21 no.8, 2825